Bli medlem
Bli medlem

Du är här


Biotage: Biotage AB - changes in number of shares and votes

As previously announced, the shareholders resolved at the Annual
General Meeting held on 28 April 2014 to withdraw 5,146,883 shares,
which had been repurchased under the company's re-purchase program.
Following withdrawal of these shares the number of outstanding shares
and votes amounts to 64,714,447 as of 30 April 2014.

Torben Jörgensen, President and CEO
Phone: +46 707-49 05 84,

Biotage discloses the information provided herein pursuant to the
Swedish Securities Markets Act and/or the Swedish Financial
Instruments Trading Act. The information was submitted for
publication at 2pm on 30 April 2014.

About Biotage
Biotage offers efficient separation technologies for use within
analytical all the way up to industrial scale as well as highly
qualitative solutions for analytical chemistry in research and at
commercial analytical laboratories. Biotage's products are used by
e.g. governmental authorities, academic institutions, pharma and food
industries. The company is headquartered in Uppsala and has offices
in the US, UK, China and Japan. Biotage has approx. 290 employees and
had sales of 445 MSEK in 2013. Biotage is listed on the NASDAQ OMX
Nordic Stockholm stock exchange. Website:


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.